PSA is not a prostate cancer-specific biomarker and analyses of blood levels are unable to discriminate between prostate cancer and other prostatic diseases, including benign prostatic hyperplasia or prostatitis1,7,8. Here, KLK3 is linked to benign prostatic hyperplasia.